Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Adaptive Cardiac Resynchronization Therapy Optimization at Rest and During Exercise (AdOPT CRT)

19 juni 2019 uppdaterad av: Medtronic Cardiac Rhythm and Heart Failure
The AdOPT Cardiac Resynchronization Therapy (CRT) study is an acute, prospective, multi-center, non-randomized investigational study designed to compare indices of cardiac function at device settings optimized using the investigational Adaptive CRT (aCRT) algorithm versus nominal programming. The comparison will be performed during rest, atrial pacing and sub-maximal exercise. AdOPT CRT is a sub study of the Adaptive CRT Study (NTC00980057) being conducted in Europe.

Studieöversikt

Status

Avslutad

Betingelser

Detaljerad beskrivning

Adaptive CRT is an implantable heart failure device feature that attempts to optimize CRT without echocardiographic testing.

Studietyp

Interventionell

Inskrivning (Faktisk)

12

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Subject is age 18 or greater
  • Subject is willing to sign and date the study Informed Consent form
  • Subject has been implanted with a clinically indicated CRT-D device (Medtronic Vision 3D or Protecta models) for at least 1 month but less than 7 months from the date of study enrollment

Exclusion Criteria:

  • Subject has a history of persistent or permanent AF for which pharmacological therapy and/or cardioversion have been unsuccessful or have not been attempted.
  • Subject has atrial or ventricular tachyarrhythmias or frequent atrial or ventricular ectopy at the time of enrollment.
  • Subject's resting heart rate at the time of enrollment exceeds 90 bpm.
  • Subject had CRT system implanted for more than 7 months from the date of the study enrollment
  • Subject has complete AV block.
  • Subject had previous mechanical valve surgeries.
  • Subject has congenital heart disease.
  • Subject has contraindication for an exercise test.
  • Subject is unable to perform a sub-maximal exercise test.
  • It is not possible to acquire technically acceptable echocardiographic images.
  • Subject has medical conditions that would limit study participation.
  • Subject is pregnant (all women of child-bearing potential must undergo a pregnancy test within seven days prior to the study visit).
  • Subject is enrolled in the Adaptive CRT study
  • Subject is enrolled in concurrent studies which could confound the results of this study.
  • Subject meets exclusion criteria required by local law

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: CRT pacing at rest and during exercise
Rest and sub-maximal exercise
CRT pacing with aCRT settings and BiV pacing with nominal programming at rest and during submaximal exercise

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Stroke Volume at Rest
Tidsram: Test day visit (within 14 days of enrollment)
Difference in stroke volume (SV) between BiV pacing with aCRT settings and BiV pacing with nominal settings at rest. Biventricular pacing is a type of pacing that paces both the right and left ventricles of the heart. Stroke volume is the volume of blood pumped from a ventricle in one heart beat.
Test day visit (within 14 days of enrollment)
Stroke Volume During Atrial Pacing.
Tidsram: Test day visit (within 14 days of enrollment)
Difference in SV between BiV pacing with aCRT settings and BiV pacing with nominal settings during atrial pacing. Atrial pacing occurs at 20 beats-per-minute (bpm) above the subject's resting heart rate.
Test day visit (within 14 days of enrollment)
Stroke Volume During Sub-maximal Exercise.
Tidsram: Test day visit (within 14 days of enrollment)
Difference in SV between BiV pacing with aCRT settings and BiV pacing with nominal settings during sub-maximal exercise. Sub-maximal exercise is exercise performed at a level below maximum effort. The subject will perform sub-maximal exercise to achieve target heart rate close to 75% of the age-predicted maximal heart rate.
Test day visit (within 14 days of enrollment)

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Cardiac Function With aCRT Settings at Rest
Tidsram: Test day visit (within 14 days of enrollment)
Difference in blood pressure (BP)-derived and echocardiogram (echo)-derived parameters of cardiac function between BiV pacing with aCRT settings and BiV pacing with nominal settings at rest.
Test day visit (within 14 days of enrollment)
Cardiac Function With Nominal Settings at Rest.
Tidsram: Test day visit (within 14 days of enrollment)
Difference in BP-derived and echo-derived parameters of cardiac function between BiV pacing with nominal settings and intrinsic conduction at rest.
Test day visit (within 14 days of enrollment)
Cardiac Function With aCRT Settings During Sub-maximal Exercise.
Tidsram: Test day visit (within 14 days of enrollment)
Difference in BP-derived and echocardiogram (echo)-derived parameters of cardiac function between BiV pacing with aCRT settings and BiV pacing with nominal settings during sub-maximal exercise.
Test day visit (within 14 days of enrollment)
Cardiac Function With Nominal Settings During Sub-maximal Exercise.
Tidsram: Test day visit (within 14 days of enrollment)
Difference in BP-derived and echo-derived parameters of cardiac function between BiV pacing with nominal settings and intrinsic conduction during sub-maximal exercise.
Test day visit (within 14 days of enrollment)
Electrical Conduction at Rest.
Tidsram: Test day visit (within 14 days of enrollment)
Electrical conduction will be evaluated at rest by measuring the subject's intrinsic atrio-ventricular (AV) interval. The AV interval is the amount time between the start of atrial contraction and the start of ventricular contraction.
Test day visit (within 14 days of enrollment)
Electrical Conduction During Sub-maximal Exercise.
Tidsram: Time Frame: Test day visit (within 14 days of enrollment)
Electrical conduction will be evaluated during sub-maximal exercise by measuring the subject's intrinsic AV interval.
Time Frame: Test day visit (within 14 days of enrollment)

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Studiestol: AdOPT CRT/aCRT Study Team, Medtronic

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 november 2011

Primärt slutförande (Faktisk)

1 mars 2012

Avslutad studie (Faktisk)

1 mars 2012

Studieregistreringsdatum

Först inskickad

16 november 2011

Först inskickad som uppfyllde QC-kriterierna

18 november 2011

Första postat (Uppskatta)

21 november 2011

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

5 augusti 2019

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

19 juni 2019

Senast verifierad

1 juni 2019

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • AdOPT CRT Sub Study

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera